Copyright Reports & Markets. All rights reserved.

Global Mesenchymal Stem Cells Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Mesenchymal Stem Cells Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Mesenchymal Stem Cells Market Size 2014-2024
        • 2.1.2 Mesenchymal Stem Cells Market Size CAGR by Region
      • 2.2 Mesenchymal Stem Cells Segment by Type
        • 2.2.1 Human MSC
        • 2.2.2 Mouse MSC
        • 2.2.3 Rat MSC
        • 2.2.4 Other
      • 2.3 Mesenchymal Stem Cells Market Size by Type
        • 2.3.1 Global Mesenchymal Stem Cells Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Mesenchymal Stem Cells Market Size Growth Rate by Type (2014-2019)
      • 2.4 Mesenchymal Stem Cells Segment by Application
        • 2.4.1 Research Institute
        • 2.4.2 Hospital
        • 2.4.3 Others
      • 2.5 Mesenchymal Stem Cells Market Size by Application
        • 2.5.1 Global Mesenchymal Stem Cells Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Mesenchymal Stem Cells Market Size Growth Rate by Application (2014-2019)

      3 Global Mesenchymal Stem Cells by Players

      • 3.1 Global Mesenchymal Stem Cells Market Size Market Share by Players
        • 3.1.1 Global Mesenchymal Stem Cells Market Size by Players (2017-2019)
        • 3.1.2 Global Mesenchymal Stem Cells Market Size Market Share by Players (2017-2019)
      • 3.2 Global Mesenchymal Stem Cells Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Mesenchymal Stem Cells by Regions

      • 4.1 Mesenchymal Stem Cells Market Size by Regions
      • 4.2 Americas Mesenchymal Stem Cells Market Size Growth
      • 4.3 APAC Mesenchymal Stem Cells Market Size Growth
      • 4.4 Europe Mesenchymal Stem Cells Market Size Growth
      • 4.5 Middle East & Africa Mesenchymal Stem Cells Market Size Growth

      5 Americas

      • 5.1 Americas Mesenchymal Stem Cells Market Size by Countries
      • 5.2 Americas Mesenchymal Stem Cells Market Size by Type
      • 5.3 Americas Mesenchymal Stem Cells Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Mesenchymal Stem Cells Market Size by Countries
      • 6.2 APAC Mesenchymal Stem Cells Market Size by Type
      • 6.3 APAC Mesenchymal Stem Cells Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Mesenchymal Stem Cells by Countries
      • 7.2 Europe Mesenchymal Stem Cells Market Size by Type
      • 7.3 Europe Mesenchymal Stem Cells Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Mesenchymal Stem Cells by Countries
      • 8.2 Middle East & Africa Mesenchymal Stem Cells Market Size by Type
      • 8.3 Middle East & Africa Mesenchymal Stem Cells Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Mesenchymal Stem Cells Market Forecast

      • 10.1 Global Mesenchymal Stem Cells Market Size Forecast (2019-2024)
      • 10.2 Global Mesenchymal Stem Cells Forecast by Regions
        • 10.2.1 Global Mesenchymal Stem Cells Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Mesenchymal Stem Cells Forecast by Type
      • 10.8 Global Mesenchymal Stem Cells Forecast by Application

      11 Key Players Analysis

      • 11.1 Lonza
        • 11.1.1 Company Details
        • 11.1.2 Mesenchymal Stem Cells Product Offered
        • 11.1.3 Lonza Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Lonza News
      • 11.2 Thermo Fisher
        • 11.2.1 Company Details
        • 11.2.2 Mesenchymal Stem Cells Product Offered
        • 11.2.3 Thermo Fisher Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Thermo Fisher News
      • 11.3 Bio-Techne
        • 11.3.1 Company Details
        • 11.3.2 Mesenchymal Stem Cells Product Offered
        • 11.3.3 Bio-Techne Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Bio-Techne News
      • 11.4 ATCC
        • 11.4.1 Company Details
        • 11.4.2 Mesenchymal Stem Cells Product Offered
        • 11.4.3 ATCC Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 ATCC News
      • 11.5 MilliporeSigma
        • 11.5.1 Company Details
        • 11.5.2 Mesenchymal Stem Cells Product Offered
        • 11.5.3 MilliporeSigma Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 MilliporeSigma News
      • 11.6 PromoCell GmbH
        • 11.6.1 Company Details
        • 11.6.2 Mesenchymal Stem Cells Product Offered
        • 11.6.3 PromoCell GmbH Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 PromoCell GmbH News
      • 11.7 Genlantis
        • 11.7.1 Company Details
        • 11.7.2 Mesenchymal Stem Cells Product Offered
        • 11.7.3 Genlantis Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Genlantis News
      • 11.8 Celprogen
        • 11.8.1 Company Details
        • 11.8.2 Mesenchymal Stem Cells Product Offered
        • 11.8.3 Celprogen Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Celprogen News
      • 11.9 Cell Applications
        • 11.9.1 Company Details
        • 11.9.2 Mesenchymal Stem Cells Product Offered
        • 11.9.3 Cell Applications Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Cell Applications News
      • 11.10 Cyagen Biosciences
        • 11.10.1 Company Details
        • 11.10.2 Mesenchymal Stem Cells Product Offered
        • 11.10.3 Cyagen Biosciences Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 Cyagen Biosciences News

      12 Research Findings and Conclusion

      Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
      In the last several years, Global market of Mesenchymal Stem Cells developed rapidly, with an average growth rate of 6.2%. In 2015, Global revenue of Mesenchymal Stem Cells is about 110 M USD.
      The global average gross margin of Mesenchymal Stem Cells is in the fluctuation trend, from 70% in 2012 to 67% in 2016. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
      The type of Mesenchymal Stem Cells includes Human, Mouse, Rat. The proportion of Human in 2015 is about 39%, and the proportion of Mouse in 2016 is about 31%.

      According to this study, over the next five years the Mesenchymal Stem Cells market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 220 million by 2024, from US$ 170 million in 2019. In particular, this report presents the global revenue market share of key companies in Mesenchymal Stem Cells business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of Mesenchymal Stem Cells market by product type, application, key companies and key regions.

      This study considers the Mesenchymal Stem Cells value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      Human MSC
      Mouse MSC
      Other
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      Research Institute
      Hospital
      Others

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Lonza
      Thermo Fisher
      Bio-Techne
      ATCC
      MilliporeSigma
      PromoCell GmbH
      Genlantis
      Celprogen
      Cell Applications
      Cyagen Biosciences

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Mesenchymal Stem Cells market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Mesenchymal Stem Cells market by identifying its various subsegments.
      Focuses on the key global Mesenchymal Stem Cells players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Mesenchymal Stem Cells with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of Mesenchymal Stem Cells submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now